| 0 |
11-DEOXYCORTICOSTERONE INCREASED |
1 |
0.3333 |
| 1 |
PLATELET DISTRIBUTION WIDTH ABNORMAL |
3 |
0.2727 |
| 2 |
CORTISOL FREE URINE INCREASED |
14 |
0.2121 |
| 3 |
SMALL CELL CARCINOMA OF THE CERVIX |
1 |
0.1667 |
| 4 |
ACTH-PRODUCING PITUITARY TUMOUR |
2 |
0.1538 |
| 5 |
MONOCYTE PERCENTAGE ABNORMAL |
3 |
0.1364 |
| 6 |
BLOOD CORTICOSTERONE INCREASED |
1 |
0.1000 |
| 7 |
ADRENAL ATROPHY |
4 |
0.0645 |
| 8 |
NEUTROPHIL PERCENTAGE ABNORMAL |
3 |
0.0638 |
| 9 |
ULTRASOUND UTERUS ABNORMAL |
3 |
0.0566 |
| 10 |
ECTOPIC ACTH SYNDROME |
3 |
0.0526 |
| 11 |
HYPERCORTICOIDISM |
5 |
0.0472 |
| 12 |
LYMPHOCYTE PERCENTAGE ABNORMAL |
3 |
0.0448 |
| 13 |
ADRENAL CARCINOMA |
2 |
0.0426 |
| 14 |
ADRENALECTOMY |
4 |
0.0417 |
| 15 |
CORTISOL INCREASED |
25 |
0.0416 |
| 16 |
NEONATAL HYPONATRAEMIA |
4 |
0.0336 |
| 17 |
HYPERPLASIA ADRENAL |
2 |
0.0323 |
| 18 |
LEGIONELLA TEST POSITIVE |
1 |
0.0323 |
| 19 |
BLOOD CORTICOTROPHIN INCREASED |
9 |
0.0320 |
| 20 |
PITUITARY TUMOUR REMOVAL |
3 |
0.0316 |
| 21 |
ADRENAL CORTICAL INSUFFICIENCY |
1 |
0.0312 |
| 22 |
HYPERADRENOCORTICISM |
8 |
0.0299 |
| 23 |
GLUCOCORTICOID DEFICIENCY |
12 |
0.0293 |
| 24 |
PITUITARY INFARCTION |
1 |
0.0233 |
| 25 |
BLOOD CORTISOL INCREASED |
5 |
0.0189 |
| 26 |
SMALL CELL LUNG CANCER RECURRENT |
1 |
0.0182 |
| 27 |
BRONCHOALVEOLAR LAVAGE |
1 |
0.0164 |
| 28 |
RED CELL DISTRIBUTION WIDTH ABNORMAL |
3 |
0.0159 |
| 29 |
PITUITARY-DEPENDENT CUSHING'S SYNDROME |
1 |
0.0152 |
| 30 |
ADRENAL GLAND CANCER METASTATIC |
1 |
0.0147 |
| 31 |
BLOOD CORTICOTROPHIN DECREASED |
7 |
0.0146 |
| 32 |
OVARIAN GRANULOSA CELL TUMOUR |
1 |
0.0139 |
| 33 |
MONOCYTE COUNT ABNORMAL |
3 |
0.0136 |
| 34 |
HIGH DENSITY LIPOPROTEIN ABNORMAL |
3 |
0.0129 |
| 35 |
PANCREATIC NEUROENDOCRINE TUMOUR METASTATIC |
3 |
0.0127 |
| 36 |
BLOOD CORTISOL ABNORMAL |
1 |
0.0125 |
| 37 |
PREMATURE BABY DEATH |
1 |
0.0123 |
| 38 |
ULTRASOUND FOETAL ABNORMAL |
1 |
0.0120 |
| 39 |
BLOOD ALDOSTERONE INCREASED |
2 |
0.0118 |
| 40 |
ADRENOCORTICAL CARCINOMA |
1 |
0.0114 |
| 41 |
RED BLOOD CELL NUCLEATED MORPHOLOGY PRESENT |
1 |
0.0111 |
| 42 |
HYPERANDROGENISM |
1 |
0.0110 |
| 43 |
MYCOTIC ENDOPHTHALMITIS |
2 |
0.0108 |
| 44 |
CORTISOL ABNORMAL |
2 |
0.0105 |
| 45 |
SUBDIAPHRAGMATIC ABSCESS |
1 |
0.0090 |
| 46 |
BLOOD BICARBONATE ABNORMAL |
1 |
0.0090 |
| 47 |
CARCINOID CRISIS |
2 |
0.0089 |
| 48 |
PROSTATIC MASS |
1 |
0.0087 |
| 49 |
CARCINOID TUMOUR PULMONARY |
2 |
0.0084 |
| 50 |
HYPERADRENALISM |
1 |
0.0082 |
| 51 |
LEUKOSTASIS SYNDROME |
1 |
0.0079 |
| 52 |
BLOOD GASTRIN INCREASED |
1 |
0.0078 |
| 53 |
CORTISOL DECREASED |
8 |
0.0072 |
| 54 |
PLATELET AGGREGATION ABNORMAL |
1 |
0.0066 |
| 55 |
MEAN CELL VOLUME ABNORMAL |
3 |
0.0065 |
| 56 |
PITUITARY HAEMORRHAGE |
2 |
0.0065 |
| 57 |
THERAPEUTIC EMBOLISATION |
2 |
0.0064 |
| 58 |
BLOOD CORTISOL DECREASED |
4 |
0.0063 |
| 59 |
HAEMODIALYSIS COMPLICATION |
1 |
0.0060 |
| 60 |
PERIPARTUM CARDIOMYOPATHY |
1 |
0.0058 |
| 61 |
BLOOD LACTIC ACID DECREASED |
1 |
0.0058 |
| 62 |
EPIDURAL LIPOMATOSIS |
2 |
0.0058 |
| 63 |
PREMATURE RUPTURE OF MEMBRANES |
13 |
0.0054 |
| 64 |
HEPATIC INFARCTION |
2 |
0.0054 |
| 65 |
ADRENOCORTICAL INSUFFICIENCY ACUTE |
10 |
0.0053 |
| 66 |
SEVERE ACUTE RESPIRATORY SYNDROME |
1 |
0.0048 |
| 67 |
EMPHYSEMATOUS CYSTITIS |
1 |
0.0047 |
| 68 |
BLOOD LACTATE DEHYDROGENASE ABNORMAL |
3 |
0.0045 |
| 69 |
FOETAL HEART RATE DECELERATION |
1 |
0.0043 |
| 70 |
PANCREATIC CARCINOMA RECURRENT |
1 |
0.0043 |
| 71 |
METASTASES TO GASTROINTESTINAL TRACT |
1 |
0.0042 |
| 72 |
ENTEROBACTER TEST POSITIVE |
1 |
0.0041 |
| 73 |
HEMIANOPIA |
4 |
0.0041 |
| 74 |
PULMONARY NOCARDIOSIS |
3 |
0.0037 |
| 75 |
RENIN INCREASED |
1 |
0.0037 |
| 76 |
HAEMORRHAGIC INFARCTION |
2 |
0.0037 |
| 77 |
ADRENAL INSUFFICIENCY |
43 |
0.0036 |
| 78 |
PNEUMOCYSTIS JIROVECII PNEUMONIA |
35 |
0.0035 |
| 79 |
PRIMARY ADRENAL INSUFFICIENCY |
1 |
0.0034 |
| 80 |
TRANSFUSION-RELATED ACUTE LUNG INJURY |
1 |
0.0034 |
| 81 |
HEPATECTOMY |
1 |
0.0033 |
| 82 |
BLOOD BETA-D-GLUCAN INCREASED |
1 |
0.0033 |
| 83 |
EYE INFECTION VIRAL |
1 |
0.0032 |
| 84 |
RED BLOOD CELL ABNORMALITY |
3 |
0.0031 |
| 85 |
PNEUMOCYSTIS JIROVECI PNEUMONIA |
7 |
0.0031 |
| 86 |
ADMINISTRATION SITE BRUISE |
1 |
0.0030 |
| 87 |
TACHYPHYLAXIS |
1 |
0.0029 |
| 88 |
SMALL CELL LUNG CANCER METASTATIC |
1 |
0.0029 |
| 89 |
NEONATAL ASPHYXIA |
2 |
0.0029 |
| 90 |
PRE-ECLAMPSIA |
13 |
0.0028 |
| 91 |
DISSEMINATED CRYPTOCOCCOSIS |
2 |
0.0028 |
| 92 |
SMALL CELL LUNG CANCER STAGE UNSPECIFIED |
1 |
0.0027 |
| 93 |
EYE INFECTION FUNGAL |
1 |
0.0027 |
| 94 |
PNEUMONIA CYTOMEGALOVIRAL |
5 |
0.0026 |
| 95 |
TRACHEOMALACIA |
1 |
0.0026 |
| 96 |
FOETAL GROWTH RETARDATION |
2 |
0.0026 |
| 97 |
FACTOR V LEIDEN MUTATION |
1 |
0.0025 |
| 98 |
HAPTOGLOBIN DECREASED |
2 |
0.0025 |
| 99 |
HYPOGLYCAEMIA NEONATAL |
4 |
0.0025 |
| 100 |
PITUITARY TUMOUR BENIGN |
4 |
0.0025 |
| 101 |
METASTASES TO SPLEEN |
1 |
0.0024 |
| 102 |
HIRSUTISM |
3 |
0.0023 |
| 103 |
PUPILLARY REFLEX IMPAIRED |
4 |
0.0022 |
| 104 |
PATIENT UNCOOPERATIVE |
1 |
0.0022 |
| 105 |
ADRENAL NEOPLASM |
1 |
0.0022 |
| 106 |
OPEN FRACTURE |
1 |
0.0021 |
| 107 |
ABDOMINAL WALL HAEMATOMA |
4 |
0.0021 |
| 108 |
IMMUNE-MEDIATED HEPATITIS |
4 |
0.0021 |
| 109 |
SKIN STRIAE |
3 |
0.0020 |
| 110 |
SECONDARY ADRENOCORTICAL INSUFFICIENCY |
3 |
0.0020 |
| 111 |
PITUITARY TUMOUR |
3 |
0.0020 |
| 112 |
PHYSICAL DECONDITIONING |
5 |
0.0020 |
| 113 |
METASTASES TO BONE MARROW |
1 |
0.0020 |
| 114 |
PROCEDURAL SITE REACTION |
1 |
0.0019 |
| 115 |
DYSPNOEA EXACERBATED |
1 |
0.0019 |
| 116 |
UNMASKING OF PREVIOUSLY UNIDENTIFIED DISEASE |
2 |
0.0019 |
| 117 |
PANCREATECTOMY |
1 |
0.0019 |
| 118 |
LEGIONELLA INFECTION |
1 |
0.0018 |
| 119 |
PO2 DECREASED |
2 |
0.0018 |
| 120 |
HEPATORENAL FAILURE |
1 |
0.0017 |
| 121 |
LOW BIRTH WEIGHT BABY |
13 |
0.0017 |
| 122 |
MEDICAL DEVICE SITE INFECTION |
1 |
0.0017 |
| 123 |
PREMATURE DELIVERY |
26 |
0.0016 |
| 124 |
LIPOHYPERTROPHY |
1 |
0.0016 |
| 125 |
PANCREATIC NEUROENDOCRINE TUMOUR |
1 |
0.0016 |
| 126 |
CUSHINGOID |
5 |
0.0016 |
| 127 |
BLOOD POTASSIUM ABNORMAL |
4 |
0.0015 |
| 128 |
AREFLEXIA |
4 |
0.0015 |
| 129 |
ATYPICAL MYCOBACTERIAL INFECTION |
2 |
0.0015 |
| 130 |
COMPUTERISED TOMOGRAM THORAX ABNORMAL |
1 |
0.0015 |
| 131 |
FOETAL HEART RATE DECELERATION ABNORMALITY |
1 |
0.0014 |
| 132 |
CUSHING'S SYNDROME |
1 |
0.0014 |
| 133 |
BLOOD TESTOSTERONE INCREASED |
3 |
0.0014 |
| 134 |
CENTRAL OBESITY |
1 |
0.0014 |
| 135 |
THROMBOTIC STROKE |
1 |
0.0014 |
| 136 |
RESPIRATORY ALKALOSIS |
2 |
0.0013 |
| 137 |
GLOMERULAR FILTRATION RATE INCREASED |
1 |
0.0012 |
| 138 |
INFECTED BITE |
1 |
0.0012 |
| 139 |
FOOD REFUSAL |
1 |
0.0012 |
| 140 |
HYPERAMMONAEMIC ENCEPHALOPATHY |
2 |
0.0012 |
| 141 |
HEPATIC CANCER METASTATIC |
1 |
0.0012 |
| 142 |
NEONATAL RESPIRATORY DISTRESS SYNDROME |
4 |
0.0011 |
| 143 |
UPPER AIRWAY OBSTRUCTION |
1 |
0.0011 |
| 144 |
METASTASES TO ADRENALS |
1 |
0.0011 |
| 145 |
NASAL CAVITY CANCER |
1 |
0.0011 |
| 146 |
FOETAL HEART RATE ABNORMAL |
1 |
0.0011 |
| 147 |
BIOPSY |
1 |
0.0011 |
| 148 |
HYPERTRICHOSIS |
2 |
0.0011 |
| 149 |
HEPATIC ENCEPHALOPATHY |
10 |
0.0011 |
| 150 |
GESTATIONAL DIABETES |
5 |
0.0011 |
| 151 |
NEUTROPHIL COUNT ABNORMAL |
3 |
0.0011 |
| 152 |
PLACENTAL DISORDER |
1 |
0.0011 |
| 153 |
CANCER SURGERY |
1 |
0.0011 |
| 154 |
ADRENAL DISORDER |
2 |
0.0011 |
| 155 |
GASTROINTESTINAL NECROSIS |
3 |
0.0010 |
| 156 |
BICYTOPENIA |
2 |
0.0010 |
| 157 |
PCO2 DECREASED |
1 |
0.0010 |
| 158 |
STEROID WITHDRAWAL SYNDROME |
1 |
0.0010 |
| 159 |
ENTEROCOCCAL BACTERAEMIA |
1 |
0.0010 |
| 160 |
BUNDLE BRANCH BLOCK LEFT |
4 |
0.0009 |
| 161 |
HYPERTENSIVE NEPHROPATHY |
1 |
0.0009 |
| 162 |
TUMOUR PSEUDOPROGRESSION |
1 |
0.0009 |
| 163 |
PNEUMONIA STREPTOCOCCAL |
1 |
0.0009 |
| 164 |
PREMATURE BABY |
27 |
0.0009 |
| 165 |
DIFFUSE ALVEOLAR DAMAGE |
1 |
0.0009 |
| 166 |
BILIRUBIN CONJUGATED INCREASED |
2 |
0.0009 |
| 167 |
HYPOCHLORAEMIA |
1 |
0.0009 |
| 168 |
SYSTEMIC MYCOSIS |
1 |
0.0009 |
| 169 |
PNEUMONIA INFLUENZAL |
1 |
0.0008 |
| 170 |
EMBOLISM ARTERIAL |
1 |
0.0008 |
| 171 |
BLEEDING TIME PROLONGED |
1 |
0.0008 |
| 172 |
SEDATION COMPLICATION |
2 |
0.0008 |
| 173 |
ANGLE CLOSURE GLAUCOMA |
2 |
0.0008 |
| 174 |
APGAR SCORE LOW |
1 |
0.0008 |
| 175 |
TUMOUR PAIN |
1 |
0.0008 |
| 176 |
METASTASES TO LYMPH NODES |
5 |
0.0008 |
| 177 |
ANION GAP INCREASED |
1 |
0.0008 |
| 178 |
ISCHAEMIC HEPATITIS |
1 |
0.0007 |
| 179 |
BILIARY TRACT DISORDER |
1 |
0.0007 |
| 180 |
HYPERGLYCAEMIA |
26 |
0.0007 |
| 181 |
PERIPHERAL ARTERY OCCLUSION |
1 |
0.0007 |
| 182 |
PERITONEAL HAEMORRHAGE |
1 |
0.0007 |
| 183 |
PREMATURE LABOUR |
4 |
0.0007 |
| 184 |
NAIL INFECTION |
1 |
0.0007 |
| 185 |
HEPATIC LESION |
3 |
0.0007 |
| 186 |
PANCREATIC ENZYMES INCREASED |
1 |
0.0007 |
| 187 |
METASTASES TO BONE |
11 |
0.0007 |
| 188 |
HEPATOCELLULAR INJURY |
9 |
0.0006 |
| 189 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
11 |
0.0006 |
| 190 |
CRYPTOCOCCOSIS |
1 |
0.0006 |
| 191 |
REBOUND EFFECT |
7 |
0.0006 |
| 192 |
PANCREATIC DISORDER |
3 |
0.0006 |
| 193 |
POTENTIATING DRUG INTERACTION |
2 |
0.0006 |
| 194 |
SPLENIC RUPTURE |
1 |
0.0006 |
| 195 |
CARDIAC FAILURE ACUTE |
4 |
0.0006 |
| 196 |
ENTEROBACTER INFECTION |
1 |
0.0006 |
| 197 |
HYPOKALAEMIA |
27 |
0.0006 |
| 198 |
EYE MOVEMENT DISORDER |
4 |
0.0006 |
| 199 |
MENINGITIS CRYPTOCOCCAL |
1 |
0.0006 |
| 200 |
BLOOD AMYLASE INCREASED |
1 |
0.0006 |
| 201 |
HYPOPITUITARISM |
1 |
0.0006 |
| 202 |
DEPRESSIVE SYMPTOM |
2 |
0.0006 |
| 203 |
DISSEMINATED INTRAVASCULAR COAGULATION |
8 |
0.0006 |
| 204 |
GASTROINTESTINAL OEDEMA |
1 |
0.0006 |
| 205 |
INTESTINAL ISCHAEMIA |
3 |
0.0006 |
| 206 |
GAMMA-GLUTAMYLTRANSFERASE INCREASED |
12 |
0.0005 |
| 207 |
OPPORTUNISTIC INFECTION |
1 |
0.0005 |
| 208 |
CATHETER PLACEMENT |
1 |
0.0005 |
| 209 |
BLOOD CHOLESTEROL DECREASED |
1 |
0.0005 |
| 210 |
THERAPEUTIC PRODUCT EFFECT VARIABLE |
2 |
0.0005 |
| 211 |
GRANULOCYTOPENIA |
3 |
0.0005 |
| 212 |
MECHANICAL VENTILATION |
1 |
0.0005 |
| 213 |
OSTEOPOROTIC FRACTURE |
1 |
0.0005 |
| 214 |
EXPOSURE VIA BREAST MILK |
2 |
0.0005 |
| 215 |
HEPATITIS |
13 |
0.0005 |
| 216 |
PNEUMONIA STAPHYLOCOCCAL |
1 |
0.0005 |
| 217 |
SMALL INTESTINAL HAEMORRHAGE |
1 |
0.0005 |
| 218 |
HYPOPHYSITIS |
1 |
0.0005 |
| 219 |
FOETAL GROWTH RESTRICTION |
3 |
0.0005 |
| 220 |
RENAL HAEMORRHAGE |
1 |
0.0005 |
| 221 |
CONCOMITANT DISEASE AGGRAVATED |
3 |
0.0005 |
| 222 |
DIVERTICULAR PERFORATION |
1 |
0.0005 |
| 223 |
SKIN HYPERPIGMENTATION |
4 |
0.0005 |
| 224 |
MUSCLE STRAIN |
4 |
0.0005 |
| 225 |
STAPHYLOCOCCAL BACTERAEMIA |
2 |
0.0005 |
| 226 |
NEOPLASM PROGRESSION |
16 |
0.0005 |
| 227 |
NOSOCOMIAL INFECTION |
1 |
0.0005 |
| 228 |
METASTASES TO MENINGES |
1 |
0.0005 |
| 229 |
MYOCARDITIS |
5 |
0.0004 |
| 230 |
CYTOMEGALOVIRUS COLITIS |
1 |
0.0004 |
| 231 |
COMPUTERISED TOMOGRAM ABNORMAL |
1 |
0.0004 |
| 232 |
EOSINOPHIL COUNT DECREASED |
1 |
0.0004 |
| 233 |
OFF LABEL USE |
372 |
0.0004 |
| 234 |
CAESAREAN SECTION |
5 |
0.0004 |
| 235 |
INTRA-ABDOMINAL HAEMORRHAGE |
1 |
0.0004 |
| 236 |
EXPOSURE DURING PREGNANCY |
26 |
0.0004 |
| 237 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
2 |
0.0004 |
| 238 |
VASODILATATION |
1 |
0.0004 |
| 239 |
MATERNAL EXPOSURE DURING PREGNANCY |
35 |
0.0004 |
| 240 |
HEPATITIS TOXIC |
1 |
0.0004 |
| 241 |
ABDOMINAL MASS |
1 |
0.0004 |
| 242 |
ASPIRATION |
4 |
0.0004 |
| 243 |
TEMPOROMANDIBULAR JOINT SYNDROME |
1 |
0.0004 |
| 244 |
BLOOD SODIUM INCREASED |
1 |
0.0004 |
| 245 |
NORMAL NEWBORN |
2 |
0.0004 |
| 246 |
PULMONARY ALVEOLAR HAEMORRHAGE |
2 |
0.0004 |
| 247 |
HYPOGLYCAEMIC COMA |
1 |
0.0004 |
| 248 |
MIXED LIVER INJURY |
1 |
0.0003 |
| 249 |
LUNG INFILTRATION |
3 |
0.0003 |
| 250 |
CREPITATIONS |
1 |
0.0003 |
| 251 |
TENSION |
2 |
0.0003 |
| 252 |
CELLULITIS |
16 |
0.0003 |
| 253 |
HEPATOTOXICITY |
7 |
0.0003 |
| 254 |
DRUG EFFECT INCREASED |
1 |
0.0003 |
| 255 |
VENTRICULAR HYPOKINESIA |
1 |
0.0003 |
| 256 |
STUPOR |
1 |
0.0003 |
| 257 |
HEPATITIS ACUTE |
2 |
0.0003 |
| 258 |
ASPERGILLUS INFECTION |
2 |
0.0003 |
| 259 |
BREAST ENLARGEMENT |
1 |
0.0003 |
| 260 |
SEPTIC SHOCK |
13 |
0.0003 |
| 261 |
METASTASES TO SPINE |
1 |
0.0003 |
| 262 |
CYTOLYTIC HEPATITIS |
1 |
0.0003 |
| 263 |
APPENDICECTOMY |
1 |
0.0003 |
| 264 |
HAEMORRHAGE SUBCUTANEOUS |
1 |
0.0003 |
| 265 |
METASTASIS |
2 |
0.0003 |
| 266 |
BONE LESION |
1 |
0.0003 |
| 267 |
ANOSMIA |
4 |
0.0003 |
| 268 |
PARADOXICAL DRUG REACTION |
1 |
0.0003 |
| 269 |
FOETAL EXPOSURE DURING PREGNANCY |
22 |
0.0003 |
| 270 |
HYPOGLYCAEMIA |
13 |
0.0003 |
| 271 |
HEPATIC NECROSIS |
1 |
0.0003 |
| 272 |
PRODUCT DOSE OMISSION IN ERROR |
7 |
0.0003 |
| 273 |
RESPIRATORY FAILURE |
19 |
0.0003 |
| 274 |
OESOPHAGEAL ULCER |
1 |
0.0003 |
| 275 |
EJECTION FRACTION DECREASED |
4 |
0.0003 |
| 276 |
CARDIOPULMONARY FAILURE |
1 |
0.0003 |
| 277 |
HYPERPHAGIA |
1 |
0.0003 |
| 278 |
BLOOD POTASSIUM INCREASED |
4 |
0.0002 |
| 279 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
6 |
0.0002 |
| 280 |
CYTOMEGALOVIRUS INFECTION |
4 |
0.0002 |
| 281 |
PULSELESS ELECTRICAL ACTIVITY |
1 |
0.0002 |
| 282 |
EMBOLISM |
2 |
0.0002 |
| 283 |
PSEUDOMONAS INFECTION |
2 |
0.0002 |
| 284 |
PULMONARY TUBERCULOSIS |
1 |
0.0002 |
| 285 |
AORTIC VALVE INCOMPETENCE |
1 |
0.0002 |
| 286 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
3 |
0.0002 |
| 287 |
METASTATIC NEOPLASM |
1 |
0.0002 |
| 288 |
ANOREXIA |
3 |
0.0002 |
| 289 |
HYPERKALAEMIA |
8 |
0.0002 |
| 290 |
METASTASES TO LIVER |
4 |
0.0002 |
| 291 |
PRODUCT DISTRIBUTION ISSUE |
2 |
0.0002 |
| 292 |
IMMUNE THROMBOCYTOPENIA |
1 |
0.0002 |
| 293 |
TACHYPNOEA |
3 |
0.0002 |
| 294 |
BLOOD PRESSURE SYSTOLIC DECREASED |
1 |
0.0002 |
| 295 |
PNEUMONIA BACTERIAL |
2 |
0.0002 |
| 296 |
MALIGNANT NEOPLASM PROGRESSION |
22 |
0.0002 |
| 297 |
OVARIAN CANCER |
2 |
0.0002 |
| 298 |
LOCALISED OEDEMA |
1 |
0.0002 |
| 299 |
HAEMATOTOXICITY |
2 |
0.0002 |
| 300 |
MYELODYSPLASTIC SYNDROME |
3 |
0.0002 |
| 301 |
STILLBIRTH |
1 |
0.0002 |
| 302 |
STAPHYLOCOCCAL SEPSIS |
1 |
0.0002 |
| 303 |
DEEP VEIN THROMBOSIS |
13 |
0.0002 |
| 304 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 305 |
CORONARY ARTERY STENOSIS |
1 |
0.0002 |
| 306 |
DYSLIPIDAEMIA |
1 |
0.0002 |
| 307 |
ENDOCARDITIS |
1 |
0.0002 |
| 308 |
DRUG-INDUCED LIVER INJURY |
6 |
0.0002 |
| 309 |
FOETAL DEATH |
1 |
0.0002 |
| 310 |
BLOOD LACTIC ACID INCREASED |
1 |
0.0002 |
| 311 |
ASPARTATE AMINOTRANSFERASE INCREASED |
10 |
0.0002 |
| 312 |
BLOOD BILIRUBIN INCREASED |
5 |
0.0002 |
| 313 |
STRESS FRACTURE |
1 |
0.0002 |
| 314 |
HYDROCEPHALUS |
1 |
0.0002 |
| 315 |
INTENTIONAL DOSE OMISSION |
5 |
0.0002 |
| 316 |
LIVER DISORDER |
8 |
0.0002 |
| 317 |
TRANSAMINASES INCREASED |
4 |
0.0002 |
| 318 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
10 |
0.0002 |
| 319 |
BLOOD CALCIUM DECREASED |
2 |
0.0002 |
| 320 |
MITRAL VALVE INCOMPETENCE |
2 |
0.0002 |
| 321 |
DRUG EXPOSURE DURING PREGNANCY |
6 |
0.0002 |
| 322 |
ELECTROLYTE IMBALANCE |
2 |
0.0002 |
| 323 |
NEOPLASM |
2 |
0.0002 |
| 324 |
GENERALISED ERYTHEMA |
1 |
0.0002 |
| 325 |
METASTASES TO LUNG |
2 |
0.0002 |
| 326 |
METABOLIC DISORDER |
1 |
0.0002 |
| 327 |
HYPOXIA |
6 |
0.0002 |
| 328 |
MULTI-ORGAN FAILURE |
3 |
0.0002 |
| 329 |
HYPOVOLAEMIA |
1 |
0.0002 |
| 330 |
GLUCOSE TOLERANCE IMPAIRED |
1 |
0.0002 |
| 331 |
POLYNEUROPATHY |
2 |
0.0002 |
| 332 |
MYOCLONUS |
2 |
0.0002 |
| 333 |
HEPATITIS CHOLESTATIC |
1 |
0.0002 |
| 334 |
PROTHROMBIN TIME PROLONGED |
1 |
0.0002 |
| 335 |
HEPATIC CYTOLYSIS |
2 |
0.0002 |
| 336 |
ALANINE AMINOTRANSFERASE INCREASED |
10 |
0.0002 |
| 337 |
AGRANULOCYTOSIS |
3 |
0.0002 |
| 338 |
CHOLANGITIS |
1 |
0.0002 |
| 339 |
HYPERCALCAEMIA |
2 |
0.0002 |
| 340 |
THROMBOCYTOPENIA |
18 |
0.0002 |
| 341 |
LEUKOPENIA |
8 |
0.0002 |
| 342 |
ABNORMAL WEIGHT GAIN |
2 |
0.0002 |
| 343 |
GASTRIC ULCER |
3 |
0.0002 |
| 344 |
CHOLESTASIS |
3 |
0.0002 |
| 345 |
THERAPY NON-RESPONDER |
7 |
0.0002 |
| 346 |
ORAL CANDIDIASIS |
2 |
0.0002 |
| 347 |
REFUSAL OF TREATMENT BY PATIENT |
1 |
0.0002 |
| 348 |
DISEASE PROGRESSION |
18 |
0.0002 |
| 349 |
CORONAVIRUS INFECTION |
1 |
0.0002 |
| 350 |
MENINGITIS |
1 |
0.0002 |
| 351 |
PRODUCT TASTE ABNORMAL |
2 |
0.0002 |
| 352 |
PRODUCT PRESCRIBING ISSUE |
3 |
0.0001 |
| 353 |
MATERNAL EXPOSURE BEFORE PREGNANCY |
1 |
0.0001 |
| 354 |
OEDEMA PERIPHERAL |
18 |
0.0001 |
| 355 |
HEPATIC ENZYME INCREASED |
10 |
0.0001 |
| 356 |
HYPERTRANSAMINASAEMIA |
1 |
0.0001 |
| 357 |
ENCEPHALITIS |
1 |
0.0001 |
| 358 |
HYPOMAGNESAEMIA |
2 |
0.0001 |
| 359 |
MENTAL STATUS CHANGES |
4 |
0.0001 |
| 360 |
PULMONARY TOXICITY |
1 |
0.0001 |
| 361 |
LYMPHOPENIA |
2 |
0.0001 |
| 362 |
ANAEMIA |
27 |
0.0001 |
| 363 |
VISUAL FIELD DEFECT |
1 |
0.0001 |
| 364 |
C-REACTIVE PROTEIN INCREASED |
5 |
0.0001 |
| 365 |
LIVER FUNCTION TEST ABNORMAL |
4 |
0.0001 |
| 366 |
PSYCHIATRIC SYMPTOM |
1 |
0.0001 |
| 367 |
HAEMODYNAMIC INSTABILITY |
1 |
0.0001 |
| 368 |
PAROSMIA |
1 |
0.0001 |
| 369 |
TOXIC EPIDERMAL NECROLYSIS |
2 |
0.0001 |
| 370 |
HEPATIC FAILURE |
4 |
0.0001 |
| 371 |
HYPERTHERMIA |
1 |
0.0001 |
| 372 |
SHOCK |
3 |
0.0001 |
| 373 |
BOWEL MOVEMENT IRREGULARITY |
1 |
0.0001 |
| 374 |
LIPASE INCREASED |
1 |
0.0001 |
| 375 |
HYPOALBUMINAEMIA |
1 |
0.0001 |
| 376 |
PRODUCT ADMINISTRATION INTERRUPTED |
1 |
0.0001 |
| 377 |
CONCUSSION |
1 |
0.0001 |
| 378 |
BLOOD ALBUMIN DECREASED |
1 |
0.0001 |
| 379 |
METABOLIC ACIDOSIS |
4 |
0.0001 |
| 380 |
DRUG INTERACTION |
20 |
0.0001 |
| 381 |
PANCYTOPENIA |
7 |
0.0001 |
| 382 |
SEPSIS |
14 |
0.0001 |
| 383 |
ATRIAL FLUTTER |
1 |
0.0001 |
| 384 |
INTERSTITIAL LUNG DISEASE |
6 |
0.0001 |
| 385 |
LIVER INJURY |
3 |
0.0001 |
| 386 |
STENT PLACEMENT |
1 |
0.0001 |
| 387 |
POST PROCEDURAL INFECTION |
1 |
0.0001 |
| 388 |
CEREBRAL INFARCTION |
3 |
0.0001 |
| 389 |
HYPERAESTHESIA |
1 |
0.0001 |
| 390 |
BLOOD PRESSURE DECREASED |
8 |
0.0001 |
| 391 |
COAGULOPATHY |
2 |
0.0001 |
| 392 |
HEMIPLEGIA |
1 |
0.0001 |
| 393 |
SPINAL COMPRESSION FRACTURE |
1 |
0.0001 |
| 394 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
2 |
0.0001 |
| 395 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
1 |
0.0001 |
| 396 |
VERTIGO |
7 |
0.0001 |
| 397 |
URINE OUTPUT DECREASED |
1 |
0.0001 |
| 398 |
CARDIOTOXICITY |
1 |
0.0001 |
| 399 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
1 |
0.0001 |
| 400 |
PULMONARY OEDEMA |
5 |
0.0001 |
| 401 |
JAUNDICE |
3 |
0.0001 |
| 402 |
VOMITING |
52 |
0.0001 |
| 403 |
OEDEMA |
6 |
0.0001 |
| 404 |
NEUTROPENIA |
15 |
0.0001 |
| 405 |
ASTHENIA |
41 |
0.0001 |
| 406 |
RESPIRATORY DISTRESS |
3 |
0.0001 |
| 407 |
RESPIRATORY ARREST |
3 |
0.0001 |
| 408 |
HYPONATRAEMIA |
6 |
0.0001 |
| 409 |
DIARRHOEA HAEMORRHAGIC |
1 |
0.0001 |
| 410 |
ACUTE RESPIRATORY FAILURE |
2 |
0.0001 |
| 411 |
HYPERCHOLESTEROLAEMIA |
1 |
0.0001 |
| 412 |
INTERNATIONAL NORMALISED RATIO INCREASED |
3 |
0.0001 |
| 413 |
DIZZINESS POSTURAL |
1 |
0.0001 |
| 414 |
RENAL TUBULAR NECROSIS |
1 |
0.0001 |
| 415 |
NAUSEA |
80 |
0.0001 |
| 416 |
LIGAMENT SPRAIN |
1 |
0.0001 |
| 417 |
BLOOD PRESSURE ABNORMAL |
2 |
0.0001 |
| 418 |
RESPIRATORY DISORDER |
3 |
0.0001 |
| 419 |
TASTE DISORDER |
2 |
0.0001 |
| 420 |
PRODUCT USE IN UNAPPROVED INDICATION |
24 |
0.0001 |
| 421 |
BONE MARROW FAILURE |
2 |
0.0001 |
| 422 |
NEUTROPHIL COUNT INCREASED |
1 |
0.0001 |
| 423 |
PERITONITIS |
2 |
0.0001 |
| 424 |
PRODUCT ODOUR ABNORMAL |
1 |
0.0001 |
| 425 |
CARDIO-RESPIRATORY ARREST |
4 |
0.0001 |
| 426 |
HYPOTENSION |
19 |
0.0001 |
| 427 |
BRADYCARDIA |
5 |
0.0001 |
| 428 |
DECREASED ACTIVITY |
1 |
0.0001 |
| 429 |
ALTERED STATE OF CONSCIOUSNESS |
2 |
0.0001 |
| 430 |
ACNE |
7 |
0.0001 |
| 431 |
BLOOD GLUCOSE FLUCTUATION |
1 |
0.0001 |
| 432 |
FEBRILE NEUTROPENIA |
6 |
0.0001 |
| 433 |
INTESTINAL PERFORATION |
1 |
0.0001 |
| 434 |
DERMATITIS CONTACT |
1 |
0.0001 |
| 435 |
IMPAIRED DRIVING ABILITY |
1 |
0.0001 |
| 436 |
PRODUCT DOSE OMISSION ISSUE |
25 |
0.0001 |
| 437 |
DECREASED APPETITE |
20 |
0.0001 |
| 438 |
VASCULITIS |
1 |
0.0001 |
| 439 |
BACTERAEMIA |
1 |
0.0001 |
| 440 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
6 |
0.0001 |
| 441 |
BLOOD IRON DECREASED |
1 |
0.0001 |
| 442 |
DYSPHAGIA |
8 |
0.0001 |
| 443 |
CHOLECYSTITIS |
1 |
0.0001 |
| 444 |
COVID-19 PNEUMONIA |
1 |
0.0001 |
| 445 |
GLOMERULAR FILTRATION RATE DECREASED |
1 |
0.0001 |
| 446 |
RESPIRATORY DEPRESSION |
1 |
0.0001 |
| 447 |
ILEUS |
1 |
0.0001 |
| 448 |
GENERALISED OEDEMA |
1 |
0.0001 |
| 449 |
HEPATIC FUNCTION ABNORMAL |
3 |
0.0001 |
| 450 |
DIZZINESS |
40 |
0.0001 |
| 451 |
MUSCULAR WEAKNESS |
9 |
0.0001 |
| 452 |
FLUID RETENTION |
4 |
0.0001 |
| 453 |
INTENTIONAL OVERDOSE |
5 |
0.0001 |
| 454 |
IMPAIRED GASTRIC EMPTYING |
1 |
0.0001 |
| 455 |
DIABETES MELLITUS |
6 |
0.0001 |
| 456 |
MYDRIASIS |
1 |
0.0001 |
| 457 |
MUCOSAL INFLAMMATION |
2 |
0.0001 |
| 458 |
HYPERTENSION |
16 |
0.0001 |
| 459 |
TREATMENT NONCOMPLIANCE |
4 |
0.0001 |
| 460 |
PULMONARY EMBOLISM |
7 |
0.0001 |
| 461 |
THERAPY INTERRUPTED |
5 |
0.0001 |
| 462 |
ORAL DISCOMFORT |
1 |
0.0001 |
| 463 |
RENAL IMPAIRMENT |
6 |
0.0001 |
| 464 |
OXYGEN SATURATION DECREASED |
4 |
0.0001 |
| 465 |
BLOOD TEST ABNORMAL |
1 |
0.0001 |
| 466 |
SEASONAL ALLERGY |
1 |
0.0001 |
| 467 |
SINUS TACHYCARDIA |
1 |
0.0001 |
| 468 |
CARDIOGENIC SHOCK |
1 |
0.0001 |
| 469 |
APATHY |
1 |
0.0001 |
| 470 |
BRAIN FOG |
1 |
0.0001 |
| 471 |
FEELING HOT |
4 |
0.0001 |
| 472 |
SOMNOLENCE |
13 |
0.0001 |
| 473 |
FATIGUE |
50 |
0.0001 |
| 474 |
HALLUCINATION, AUDITORY |
1 |
0.0001 |
| 475 |
ABSCESS |
1 |
0.0001 |
| 476 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
1 |
0.0001 |
| 477 |
INFECTION |
9 |
0.0001 |
| 478 |
LACTIC ACIDOSIS |
2 |
0.0001 |
| 479 |
BLOOD CREATININE INCREASED |
4 |
0.0001 |
| 480 |
MANIA |
1 |
0.0001 |
| 481 |
DRUG LEVEL INCREASED |
1 |
0.0001 |
| 482 |
DEHYDRATION |
8 |
0.0001 |
| 483 |
CANDIDA INFECTION |
1 |
0.0001 |
| 484 |
RENAL FAILURE |
8 |
0.0001 |
| 485 |
CONDITION AGGRAVATED |
18 |
0.0001 |
| 486 |
BLOOD UREA INCREASED |
1 |
0.0001 |
| 487 |
ACUTE KIDNEY INJURY |
9 |
0.0001 |
| 488 |
FACE OEDEMA |
1 |
0.0001 |
| 489 |
PNEUMONIA |
19 |
0.0001 |
| 490 |
CIRCULATORY COLLAPSE |
1 |
0.0001 |
| 491 |
BALANCE DISORDER |
5 |
0.0001 |
| 492 |
PARANOIA |
1 |
0.0001 |
| 493 |
GASTRIC DISORDER |
2 |
0.0001 |
| 494 |
DIABETES MELLITUS INADEQUATE CONTROL |
1 |
0.0001 |
| 495 |
BLOOD TRIGLYCERIDES INCREASED |
1 |
0.0001 |
| 496 |
RESTLESS LEGS SYNDROME |
1 |
0.0001 |
| 497 |
CONJUNCTIVITIS |
1 |
0.0001 |
| 498 |
BACTERIAL INFECTION |
1 |
0.0001 |
| 499 |
PRODUCT USE ISSUE |
10 |
0.0001 |
| 500 |
INCREASED APPETITE |
1 |
0.0001 |
| 501 |
BLOOD SODIUM DECREASED |
1 |
0.0001 |
| 502 |
HYPOCALCAEMIA |
1 |
0.0001 |
| 503 |
GENERAL PHYSICAL HEALTH DETERIORATION |
6 |
0.0001 |
| 504 |
LETHARGY |
3 |
0.0001 |
| 505 |
DIARRHOEA |
33 |
0.0001 |
| 506 |
ATRIAL FIBRILLATION |
5 |
0.0001 |
| 507 |
BLOOD PRESSURE SYSTOLIC INCREASED |
1 |
0.0001 |
| 508 |
MEMORY IMPAIRMENT |
7 |
0.0001 |
| 509 |
ALOPECIA |
10 |
0.0001 |
| 510 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
2 |
0.0001 |
| 511 |
DISORIENTATION |
2 |
0.0001 |
| 512 |
PRODUCT PHYSICAL ISSUE |
1 |
0.0001 |
| 513 |
SPINAL FRACTURE |
1 |
0.0001 |
| 514 |
FEEDING DISORDER |
1 |
0.0001 |
| 515 |
ABNORMAL BEHAVIOUR |
2 |
0.0001 |
| 516 |
DRUG INEFFECTIVE |
66 |
0.0001 |
| 517 |
HAEMATOCRIT DECREASED |
1 |
0.0001 |
| 518 |
CARDIAC FAILURE |
4 |
0.0001 |
| 519 |
ACTIVITIES OF DAILY LIVING IMPAIRED |
1 |
0.0001 |
| 520 |
ABORTION SPONTANEOUS |
2 |
0.0001 |
| 521 |
FULL BLOOD COUNT DECREASED |
1 |
0.0001 |
| 522 |
RIB FRACTURE |
1 |
0.0000 |
| 523 |
RHABDOMYOLYSIS |
2 |
0.0000 |
| 524 |
HAEMORRHAGE |
5 |
0.0000 |
| 525 |
WITHDRAWAL SYNDROME |
2 |
0.0000 |
| 526 |
RETCHING |
1 |
0.0000 |
| 527 |
VAGINAL HAEMORRHAGE |
2 |
0.0000 |
| 528 |
PLATELET COUNT DECREASED |
5 |
0.0000 |
| 529 |
LIVER FUNCTION TEST INCREASED |
1 |
0.0000 |
| 530 |
EATING DISORDER |
1 |
0.0000 |
| 531 |
CLOSTRIDIUM DIFFICILE INFECTION |
1 |
0.0000 |
| 532 |
PRURITUS GENERALISED |
1 |
0.0000 |
| 533 |
MALAISE |
20 |
0.0000 |
| 534 |
COVID-19 |
8 |
0.0000 |
| 535 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 536 |
HEART RATE IRREGULAR |
1 |
0.0000 |
| 537 |
ADVERSE EVENT |
4 |
0.0000 |
| 538 |
TREMOR |
7 |
0.0000 |
| 539 |
DISEASE RECURRENCE |
2 |
0.0000 |
| 540 |
DYSPEPSIA |
4 |
0.0000 |
| 541 |
PYREXIA |
14 |
0.0000 |
| 542 |
PNEUMONIA ASPIRATION |
1 |
0.0000 |
| 543 |
HYPOAESTHESIA |
6 |
0.0000 |
| 544 |
AGEUSIA |
1 |
0.0000 |
| 545 |
HOT FLUSH |
3 |
0.0000 |
| 546 |
DEATH |
34 |
0.0000 |
| 547 |
HYPOPHAGIA |
1 |
0.0000 |
| 548 |
HAEMATEMESIS |
1 |
0.0000 |
| 549 |
DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS |
1 |
0.0000 |
| 550 |
CARDIOVASCULAR DISORDER |
1 |
0.0000 |
| 551 |
LOSS OF CONSCIOUSNESS |
5 |
0.0000 |
| 552 |
DRUG RESISTANCE |
1 |
0.0000 |
| 553 |
SKIN ULCER |
1 |
0.0000 |
| 554 |
ABDOMINAL PAIN |
9 |
0.0000 |
| 555 |
MENSTRUATION IRREGULAR |
1 |
0.0000 |
| 556 |
EAR INFECTION |
1 |
0.0000 |
| 557 |
PRODUCT QUALITY ISSUE |
5 |
0.0000 |
| 558 |
CONFUSIONAL STATE |
6 |
0.0000 |
| 559 |
PNEUMONITIS |
1 |
0.0000 |
| 560 |
DISTURBANCE IN ATTENTION |
2 |
0.0000 |
| 561 |
LIMB INJURY |
1 |
0.0000 |
| 562 |
MOOD ALTERED |
1 |
0.0000 |
| 563 |
PROCEDURAL PAIN |
1 |
0.0000 |
| 564 |
ABDOMINAL DISCOMFORT |
6 |
0.0000 |
| 565 |
WEIGHT DECREASED |
10 |
0.0000 |
| 566 |
HAEMOPTYSIS |
1 |
0.0000 |
| 567 |
FLATULENCE |
2 |
0.0000 |
| 568 |
URINARY TRACT INFECTION |
6 |
0.0000 |
| 569 |
PAIN IN JAW |
1 |
0.0000 |
| 570 |
HEADACHE |
22 |
0.0000 |
| 571 |
ANGINA PECTORIS |
1 |
0.0000 |
| 572 |
BACK PAIN |
8 |
0.0000 |
| 573 |
INTENTIONAL PRODUCT USE ISSUE |
3 |
0.0000 |
| 574 |
ASCITES |
1 |
0.0000 |
| 575 |
GASTROINTESTINAL DISORDER |
3 |
0.0000 |
| 576 |
PSYCHOTIC DISORDER |
1 |
0.0000 |
| 577 |
RENAL INJURY |
1 |
0.0000 |
| 578 |
JOINT SWELLING |
4 |
0.0000 |
| 579 |
THERAPEUTIC RESPONSE DECREASED |
2 |
0.0000 |
| 580 |
SUICIDE ATTEMPT |
2 |
0.0000 |
| 581 |
HOSPITALISATION |
5 |
0.0000 |
| 582 |
EPILEPSY |
1 |
0.0000 |
| 583 |
HEAD INJURY |
1 |
0.0000 |
| 584 |
DRUG INTOLERANCE |
3 |
0.0000 |
| 585 |
HIP FRACTURE |
1 |
0.0000 |
| 586 |
HYPERHIDROSIS |
4 |
0.0000 |
| 587 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 588 |
URINARY RETENTION |
1 |
0.0000 |
| 589 |
FUNGAL INFECTION |
1 |
0.0000 |
| 590 |
ILLNESS |
3 |
0.0000 |
| 591 |
TYPE 2 DIABETES MELLITUS |
1 |
0.0000 |
| 592 |
TRANSIENT ISCHAEMIC ATTACK |
1 |
0.0000 |
| 593 |
MYELOSUPPRESSION |
1 |
0.0000 |
| 594 |
FLUSHING |
3 |
0.0000 |
| 595 |
HAEMOGLOBIN DECREASED |
3 |
0.0000 |
| 596 |
DELIRIUM |
1 |
0.0000 |
| 597 |
ABDOMINAL DISTENSION |
3 |
0.0000 |
| 598 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 599 |
STRESS |
2 |
0.0000 |
| 600 |
ELECTROCARDIOGRAM QT PROLONGED |
1 |
0.0000 |
| 601 |
WHITE BLOOD CELL COUNT DECREASED |
3 |
0.0000 |
| 602 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
1 |
0.0000 |
| 603 |
AGITATION |
2 |
0.0000 |
| 604 |
WEIGHT INCREASED |
6 |
0.0000 |
| 605 |
DYSPNOEA EXERTIONAL |
1 |
0.0000 |
| 606 |
DYSARTHRIA |
1 |
0.0000 |
| 607 |
SEIZURE |
3 |
0.0000 |
| 608 |
WHITE BLOOD CELL COUNT INCREASED |
1 |
0.0000 |
| 609 |
PARAESTHESIA |
4 |
0.0000 |
| 610 |
PSORIATIC ARTHROPATHY |
1 |
0.0000 |
| 611 |
DYSPNOEA |
14 |
0.0000 |
| 612 |
ABDOMINAL PAIN UPPER |
5 |
0.0000 |
| 613 |
OSTEOPOROSIS |
1 |
0.0000 |
| 614 |
CARDIAC ARREST |
2 |
0.0000 |
| 615 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 616 |
CONSTIPATION |
5 |
0.0000 |
| 617 |
ANGIOEDEMA |
1 |
0.0000 |
| 618 |
TACHYCARDIA |
2 |
0.0000 |
| 619 |
THROAT IRRITATION |
1 |
0.0000 |
| 620 |
ADVERSE DRUG REACTION |
2 |
0.0000 |
| 621 |
LOWER RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 622 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 623 |
COGNITIVE DISORDER |
1 |
0.0000 |
| 624 |
BLOOD CHOLESTEROL INCREASED |
1 |
0.0000 |
| 625 |
CARDIAC DISORDER |
2 |
0.0000 |
| 626 |
COMA |
1 |
0.0000 |
| 627 |
GAIT DISTURBANCE |
4 |
0.0000 |
| 628 |
BLOOD GLUCOSE DECREASED |
1 |
0.0000 |
| 629 |
LUNG DISORDER |
1 |
0.0000 |
| 630 |
HEART RATE INCREASED |
2 |
0.0000 |
| 631 |
BLOOD PRESSURE INCREASED |
3 |
0.0000 |
| 632 |
PANCREATITIS |
1 |
0.0000 |
| 633 |
RASH PRURITIC |
1 |
0.0000 |
| 634 |
PAIN |
11 |
0.0000 |
| 635 |
TOXICITY TO VARIOUS AGENTS |
3 |
0.0000 |
| 636 |
MYALGIA |
3 |
0.0000 |
| 637 |
HERPES ZOSTER |
1 |
0.0000 |
| 638 |
SURGERY |
1 |
0.0000 |
| 639 |
BONE PAIN |
1 |
0.0000 |
| 640 |
WHEEZING |
1 |
0.0000 |
| 641 |
CATARACT |
1 |
0.0000 |
| 642 |
PLEURAL EFFUSION |
1 |
0.0000 |
| 643 |
VISUAL IMPAIRMENT |
2 |
0.0000 |
| 644 |
HYPERSENSITIVITY |
3 |
0.0000 |
| 645 |
BLOOD GLUCOSE INCREASED |
3 |
0.0000 |
| 646 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
3 |
0.0000 |
| 647 |
ARTHRALGIA |
6 |
0.0000 |
| 648 |
BURNING SENSATION |
1 |
0.0000 |
| 649 |
MOBILITY DECREASED |
1 |
0.0000 |
| 650 |
UNDERDOSE |
1 |
0.0000 |
| 651 |
PAIN IN EXTREMITY |
4 |
0.0000 |
| 652 |
DEPRESSION |
3 |
0.0000 |
| 653 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 654 |
PERIPHERAL SWELLING |
2 |
0.0000 |
| 655 |
FEELING ABNORMAL |
3 |
0.0000 |
| 656 |
GASTROOESOPHAGEAL REFLUX DISEASE |
1 |
0.0000 |
| 657 |
THROMBOSIS |
1 |
0.0000 |
| 658 |
CARDIAC FAILURE CONGESTIVE |
1 |
0.0000 |
| 659 |
PROSTATE CANCER |
1 |
0.0000 |
| 660 |
INFLUENZA LIKE ILLNESS |
1 |
0.0000 |
| 661 |
FALL |
4 |
0.0000 |
| 662 |
DRUG DOSE OMISSION |
2 |
0.0000 |
| 663 |
MUSCULOSKELETAL STIFFNESS |
1 |
0.0000 |
| 664 |
NO ADVERSE EVENT |
2 |
0.0000 |
| 665 |
INSOMNIA |
3 |
0.0000 |
| 666 |
MUSCLE SPASMS |
2 |
0.0000 |
| 667 |
OROPHARYNGEAL PAIN |
1 |
0.0000 |
| 668 |
SWELLING |
1 |
0.0000 |
| 669 |
BREAST CANCER |
1 |
0.0000 |
| 670 |
CONTUSION |
1 |
0.0000 |
| 671 |
SYNCOPE |
1 |
0.0000 |
| 672 |
CHEST DISCOMFORT |
1 |
0.0000 |
| 673 |
OVERDOSE |
2 |
0.0000 |
| 674 |
INFLUENZA |
1 |
0.0000 |
| 675 |
CHILLS |
1 |
0.0000 |
| 676 |
VISION BLURRED |
1 |
0.0000 |
| 677 |
COUGH |
2 |
0.0000 |
| 678 |
ANXIETY |
2 |
0.0000 |
| 679 |
URTICARIA |
1 |
0.0000 |
| 680 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
1 |
0.0000 |
| 681 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 682 |
PRURITUS |
1 |
0.0000 |